We Have Medical Device Treatment to Address ADHD Medication Shortages

A straightforward argument

Welcome to The Frontier Psychiatrists—a newsletter about health, health policy, and medical innovations; a psychiatrist writes it. Owen Scott Muir, M.D. is that M.D. and his training was completed in Child, Adolescent, and General Psychiatry.

Today, we address the stimulant shortage with an actual solution—I’m describing a medical device that treats ADHD. This is a reader-supported newsletter, and I have no financial relationship with the company that makes it. I’m not an advisor, equity holder, or the like. I have no financial conflict of interest, but I’ll take one!¹ I have a COI² with you, dear readers, in that your subscriptions bias me towards more writing about topics like this. The device, made by Neurosigma, looks like this:

The initial research was on veterans with PTSD, but the initial go-to-market was pediatric ADHD.

My practice, Fermata, specializes in noninvasive neuromodulation. In the context of ADHD, we prescribe the Monarch eTNS device.  The Monarch device is FDA-…